February 14, 2025
GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced ultraRapid Whole Genome Sequencing,…
February 14, 2025
Baltimore’s Elixirgen Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation
BALTIMORE, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on treating rare diseases, today…
February 13, 2025
SSTI – Useful Stats: Which businesses are potentially impacted by the NIH F&A rate change?
By Conor Gowder & Mark Skinner The Feb. 7, 2025, memo from the NIH Office of the Director (NOT-OD-25-068), now…
February 13, 2025
TEDCO Announces FY2025 SBIR/STTR Proposal Lab Cohort
The sixth cohort will undergo the first iteration of the program’s new structure COLUMBIA, Md., (February 13, 2025) — TEDCO,…
February 12, 2025
Volition: Celebrating women in science: empowering the future
As we celebrate Women in Science Day and Women’s History Month, we are proud to spotlight the women of Volition. …
February 12, 2025
MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs
TG Therapeutics to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support the development and commercialization of azer-cel, its…
February 10, 2025
Maryland Economic Headwinds? Time to Invest in Economies of the Future
By Brian Darmody: While the Maryland economy is facing budget uncertainties, the state can help surmount these challenges by growing…
February 10, 2025
New GW Study Highlights Importance of Measuring Well-Being in Mental Health Research
New Study Highlights Importance of Measuring Well-Being in Mental Health Research WASHINGTON (February 10, 2025) – A new study published…
February 10, 2025
Previous BHCR Crab Trap Winner LifeSprout Completes CE Mark Submission for Lumina™, a Next-Generation Aesthetics Dermal Filler
BALTIMORE, Jan. 23, 2025 /PRNewswire/ -- LifeSprout, a privately held regenerative medicine company founded with technology licensed from Johns Hopkins University, today announced…